Kathryn A Chung

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi request reprint Short-term paroxetine treatment does not alter the motor response to levodopa in PD
    Kathryn A Chung
    Oregon Health and Science University, Portland, OR 97239 3098, USA
    Neurology 64:1797-8. 2005
  2. pmc Objective measurement of dyskinesia in Parkinson's disease using a force plate
    Kathryn A Chung
    Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA
    Mov Disord 25:602-8. 2010
  3. pmc Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
    Kathryn A Chung
    Department of Neurology, Oregon Health and Science University, Portland, OR, USA
    Neurology 75:1263-9. 2010
  4. pmc CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
    Jing Zhang
    Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104, USA
    Am J Clin Pathol 129:526-9. 2008

Detail Information

Publications4

  1. ncbi request reprint Short-term paroxetine treatment does not alter the motor response to levodopa in PD
    Kathryn A Chung
    Oregon Health and Science University, Portland, OR 97239 3098, USA
    Neurology 64:1797-8. 2005
    ..Paroxetine did not affect tapping scores or dyskinesia. Baseline walking speed (preinfusion) increased on paroxetine, often associated with an increased subjective perception of worsened balance...
  2. pmc Objective measurement of dyskinesia in Parkinson's disease using a force plate
    Kathryn A Chung
    Department of Neurology, Oregon Health and Science University, Portland, Oregon, USA
    Mov Disord 25:602-8. 2010
    ..Sensitivity to changes in LID was initially demonstrated but should be repeated. Thus, CoP recordings on a force plate can objectively quantify LID in PD and may be very useful in clinical trials or other investigations of dyskinesia...
  3. pmc Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease
    Kathryn A Chung
    Department of Neurology, Oregon Health and Science University, Portland, OR, USA
    Neurology 75:1263-9. 2010
    ..To investigate if a central cholinesterase inhibitor will reduce falling frequency in subjects with Parkinson disease (PD) with advanced postural instability...
  4. pmc CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
    Jing Zhang
    Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104, USA
    Am J Clin Pathol 129:526-9. 2008
    ..This first large-scale validation of a proteomic-discovered MAP suggests a panel of 8 CSF proteins that are highly effective at identifying PD and moderately effective at identifying AD...